John Konsin is the co-founder and CEO of Prapela, a Portland-based startup that just received ‘De Novo’ authorization from the FDA for its bassinet-pad innovation. FILE PHOTO / TIM GREENWAY ...

The Prapela SVS hospital bassinet pad is indicated as adjunctive non-pharmacological therapy in newborns ≥37 weeks gestational age exposed prenatally to opioids with neonatal opioid withdrawal ...